` 603351 (Nanjing Well Pharmaceutical Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

N
603351
vs
S
Shanghai Composite

Over the past 12 months, Nanjing Well Pharmaceutical Co Ltd has underperformed Shanghai Composite, delivering a return of +7% compared to the Shanghai Composite's +24% growth.

Stocks Performance
603351 vs Shanghai Composite

Loading
603351
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
603351 vs Shanghai Composite

Loading
603351
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
603351 vs Shanghai Composite

Loading
603351
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Nanjing Well Pharmaceutical Co Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Nanjing Well Pharmaceutical Co Ltd
Glance View

Market Cap
3.7B CNY
Industry
Chemicals

Nanjing Well Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils. The company is headquartered in Nanjing, Jiangsu and currently employs 615 full-time employees. The company went IPO on 2019-01-30. Its main products include pharmaceutical auxiliary materials, synthetic lubricating base oil and pesticide additives. The firm distributes its products primarily in domestic market.

Intrinsic Value
27.83 CNY
Undervaluation 3%
Intrinsic Value
Price
N
Back to Top